Harbor Investment Advisory’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $203K | Hold |
1,604
| – | – | 0.02% | 368 |
|
2025
Q1 | $205K | Sell |
1,604
-100
| -6% | -$12.8K | 0.02% | 365 |
|
2024
Q4 | $225K | Sell |
1,704
-311
| -15% | -$41.1K | 0.02% | 337 |
|
2024
Q3 | $293K | Hold |
2,015
| – | – | 0.03% | 291 |
|
2024
Q2 | $277K | Sell |
2,015
-357
| -15% | -$49K | 0.03% | 291 |
|
2024
Q1 | $325K | Sell |
2,372
-645
| -21% | -$88.5K | 0.03% | 268 |
|
2023
Q4 | $410K | Buy |
3,017
+20
| +0.7% | +$2.72K | 0.05% | 237 |
|
2023
Q3 | $367K | Buy |
2,997
+67
| +2% | +$8.19K | 0.05% | 241 |
|
2023
Q2 | $372K | Sell |
2,930
-160
| -5% | -$20.3K | 0.05% | 258 |
|
2023
Q1 | $399K | Hold |
3,090
| – | – | 0.06% | 243 |
|
2022
Q4 | $406K | Sell |
3,090
-375
| -11% | -$49.2K | 0.06% | 233 |
|
2022
Q3 | $405K | Hold |
3,465
| – | – | 0.07% | 223 |
|
2022
Q2 | $408K | Sell |
3,465
-2
| -0.1% | -$235 | 0.07% | 226 |
|
2022
Q1 | $452K | Buy |
3,467
+995
| +40% | +$130K | 0.06% | 234 |
|
2021
Q4 | $377K | Buy |
2,472
+680
| +38% | +$104K | 0.05% | 256 |
|
2021
Q3 | $290K | Buy |
1,792
+531
| +42% | +$85.9K | 0.04% | 293 |
|
2021
Q2 | $206K | Hold |
1,261
| – | – | 0.03% | 365 |
|
2021
Q1 | $190K | Buy |
1,261
+271
| +27% | +$40.8K | 0.03% | 348 |
|
2020
Q4 | $150K | Buy |
990
+135
| +16% | +$20.5K | 0.02% | 366 |
|
2020
Q3 | $116K | Hold |
855
| – | – | 0.02% | 349 |
|
2020
Q2 | $117K | Buy |
855
+50
| +6% | +$6.84K | 0.02% | 328 |
|
2020
Q1 | $87K | Sell |
805
-200
| -20% | -$21.6K | 0.02% | 330 |
|
2019
Q4 | $121K | Buy |
+1,005
| New | +$121K | 0.03% | 304 |
|